Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Evaluation of early atherosclerosis in patients with inflammatory bowel disease.

Kayahan H, Sari I, Cullu N, Yuksel F, Demir S, Akarsu M, Goktay Y, Unsal B, Akpinar H.

Dig Dis Sci. 2012 Aug;57(8):2137-43. doi: 10.1007/s10620-012-2148-x. Epub 2012 Apr 1.

PMID:
22466100
2.

Endothelial function and cardiovascular risk in active inflammatory bowel diseases.

Principi M, Mastrolonardo M, Scicchitano P, Gesualdo M, Sassara M, Guida P, Bucci A, Zito A, Caputo P, Albano F, Ierardi E, Di Leo A, Ciccone MM.

J Crohns Colitis. 2013 Nov;7(10):e427-33. doi: 10.1016/j.crohns.2013.02.001. Epub 2013 Mar 7.

PMID:
23473915
3.

Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.

Ozturk K, Guler AK, Cakir M, Ozen A, Demirci H, Turker T, Demirbas S, Uygun A, Gulsen M, Bagci S.

Inflamm Bowel Dis. 2015 Jun;21(6):1314-20. doi: 10.1097/MIB.0000000000000355.

4.

Aortic Intima-Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease.

Aloi M, Tromba L, Rizzo V, D'Arcangelo G, Dilillo A, Blasi S, Civitelli F, Kiltzanidi D, Redler A, Viola F.

J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):41-6. doi: 10.1097/MPG.0000000000000771.

PMID:
26039941
5.

Premature subclinical atherosclerosis in pediatric inflammatory bowel disease.

Aloi M, Tromba L, Di Nardo G, Dilillo A, Del Giudice E, Marocchi E, Viola F, Civitelli F, Berni A, Cucchiara S.

J Pediatr. 2012 Oct;161(4):589-94.e1. doi: 10.1016/j.jpeds.2012.03.043. Epub 2012 May 10.

PMID:
22579000
6.

Evaluation of increased subclinical atherosclerosis risk with carotid intima-media thickness and pulse wave velocity in inflamatory bowel disease.

Alkan E, Karakaş MS, Yıldırım B.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:20-5. doi: 10.5152/tjg.2014.5036.

7.

Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.

Cappello M, Licata A, Calvaruso V, Bravatà I, Aiello A, Torres D, Della Corte V, Tuttolomondo A, Perticone M, Licata G, Craxì A, Cammà C.

Eur J Intern Med. 2017 Jan;37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.

PMID:
27773555
8.

Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.

Üstün Y, Kilincalp S, Çoban Ş, Coşkun Y, Yüksel İ, Ongun A, Soykan İ, Bektaş M, Törüner M, Çetinkaya H, Örmeci N.

Med Sci Monit. 2016 Oct 24;22:3943-3950.

9.

Impaired endothelial function in patients with ankylosing spondylitis.

Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N.

Rheumatology (Oxford). 2006 Mar;45(3):283-6. Epub 2005 Oct 4.

PMID:
16204374
10.

Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.

Caliskan Z, Gokturk HS, Caliskan M, Gullu H, Ciftci O, Ozgur GT, Guven A, Selcuk H.

Microvasc Res. 2015 Jan;97:25-30. doi: 10.1016/j.mvr.2014.08.003. Epub 2014 Aug 14.

PMID:
25128749
11.

Evaluation of serum sCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study.

Erturan I, Köroğlu BK, Adiloğlu A, Ceyhan AM, Akkaya VB, Tamer N, Başak PY, Korkmaz S, Ersoy IH, Kilinç O.

Int J Dermatol. 2014 Apr;53(4):503-9.

PMID:
24673360
12.

Early atherosclerosis in patients with inflammatory bowel disease.

Papa A, Danese S, Urgesi R, Grillo A, Guglielmo S, Roberto I, Bonizzi M, Guidi L, De Vitis I, Santoliquido A, Fedeli G, Gasbarrini G, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):7-11.

PMID:
16494104
13.

Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease.

Koutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA.

Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1147-52.

PMID:
15489574
14.

Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase.

Principi M, Montenegro L, Losurdo G, Zito A, Devito F, Bulzis G, Carbonara R, Ierardi E, Di Leo A, Ciccone MM.

Scand J Gastroenterol. 2016;51(2):253-5. doi: 10.3109/00365521.2015.1070901. Epub 2015 Jul 25. No abstract available.

PMID:
26212627
15.

Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors.

Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Higashi Y.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2295-303. doi: 10.1161/ATVBAHA.112.249680. Epub 2012 Jul 12.

16.

Local association between endothelial dysfunction and intimal hyperplasia: relevance in peripheral artery disease.

Heinen Y, Stegemann E, Sansone R, Benedens K, Wagstaff R, Balzer J, Rassaf T, Lauer T, Kelm M, Heiss C.

J Am Heart Assoc. 2015 Feb 3;4(2). pii: e001472. doi: 10.1161/JAHA.114.001472.

17.

Early atherosclerosis in ulcerative colitis: cross-sectional case-control study.

Jain SS, Shah DK, Gambhire PA, Varma RU, Contractor QQ, Rathi PM.

J Dig Dis. 2015 Nov;16(11):656-64. doi: 10.1111/1751-2980.12297.

PMID:
26512945
18.

Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.

Szucs G, Tímár O, Szekanecz Z, Dér H, Kerekes G, Szamosi S, Shoenfeld Y, Szegedi G, Soltész P.

Rheumatology (Oxford). 2007 May;46(5):759-62. Epub 2007 Jan 23.

PMID:
17244666
19.

Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men.

Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K, Kim S, Toba K, Yoshizumi M, Ouchi Y.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2795-800.

20.

Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.

Mikołajczyk TP, Osmenda G, Batko B, Wilk G, Krezelok M, Skiba D, Sliwa T, Pryjma JR, Guzik TJ.

Lupus. 2016 Jan;25(1):18-27. doi: 10.1177/0961203315598014. Epub 2015 Aug 6.

PMID:
26251402

Supplemental Content

Support Center